Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €15.69 EUR
Change Today +0.149 / 0.96%
Volume 0.0
BSX On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 1:44 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for boston scientific corp (BSX)

Year over year, Boston Scientific Corporation has been able to grow revenues from $7.1B USD to $7.3B USD. Most impressively, the company has been able to reduce the percentage of sales devoted to income tax expense from -1.44% to -5.34%. This was a driver that led to an improvement in the bottom line from a loss of $121.0M USD to a smaller loss of $119.0M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Reclassified
Dec 31
2012
Restated
Dec 31
2013
Restated
Dec 31
2014
4 Year
Trend
Revenues7,622.07,249.07,070.07,308.0
TOTAL REVENUES7,622.07,249.07,070.07,308.0
Cost of Goods Sold2,795.02,494.02,241.02,225.0
GROSS PROFIT4,827.04,755.04,829.05,083.0
Selling General & Admin Expenses, Total2,483.02,519.02,651.02,878.0
R&D Expenses895.0886.0861.0817.0
Depreciation & Amortization, Total421.0395.0410.0438.0
OTHER OPERATING EXPENSES, TOTAL3,799.03,800.03,922.04,133.0
OPERATING INCOME1,028.0955.0907.0950.0
Interest Expense-281.0-261.0-324.0-216.0
Interest and Investment Income7.05.06.05.0
NET INTEREST EXPENSE-274.0-256.0-318.0-211.0
Income (Loss) on Equity Investments-----2.0--
Currency Exchange Gains (Loss)-12.0-18.0-11.0-18.0
Other Non-Operating Income (Expenses)-3.0-2.0-5.0-6.0
EBT, EXCLUDING UNUSUAL ITEMS739.0679.0571.0715.0
Merger & Restructuring Charges-129.0-160.0-124.0-117.0
Impairment of Goodwill-697.0-4,350.0-423.0--
Gain (Loss) on Sale of Investments27.037.0-7.027.0
Gain (Loss) on Sale of Assets778.015.038.012.0
Other Unusual Items, Total-76.0-328.0-278.0-1,146.0
In Process R&D Expenses---142.0-53.0-88.0
Legal Settlements-48.0-192.0-221.0-1,036.0
Other Unusual Items-7.06.0-4.085.0
EBT, INCLUDING UNUSUAL ITEMS642.0-4,107.0-223.0-509.0
Income Tax Expense201.0-39.0-102.0-390.0
Earnings from Continuing Operations441.0-4,068.0-121.0-119.0
NET INCOME441.0-4,068.0-121.0-119.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS441.0-4,068.0-121.0-119.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS441.0-4,068.0-121.0-119.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BSX:GR €15.69 EUR +0.149

BSX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Becton Dickinson and Co $152.35 USD -0.08
Olympus Corp ¥4,840 JPY +80.00
St Jude Medical Inc $72.76 USD -0.64
Stryker Corp $101.48 USD -0.03
Zimmer Biomet Holdings Inc $103.13 USD -1.20
View Industry Companies
 

Industry Analysis

BSX

Industry Average

Valuation BSX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.2x
Price/Book 3.5x
Price/Cash Flow 78.1x
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOSTON SCIENTIFIC CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.